Intec, a clinical-stage biotech that develops drugs based on its proprietary Accordion Pill platform technology, said top-line data from a pivotal Phase 3 trial dubbed ACCORDANCE did not achieve the ...
JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...
A phase 3 trial of Intec Pharma’s Parkinson's disease drug has missed its primary endpoint, sparking a steep decline in the company’s stock. The candidate uses a drug delivery system designed to ...
- At market open on July 27, 2021, Intec US will begin trading on the Nasdaq Capital Market instead of Intec Israel under Intec Israel's existing symbol "NTEC" H.C. Wainwright & Co. is acting as the ...
Intec Pharma, maker of the Accordian Pill delivery platform, secured a $5.2 million grant from the Israeli government to support late-stage R&D for its Parkinson’s candidate, which makes use of the ...
KUALA LUMPUR--UK-based telecommunications software provider Intec Telecom Systems PLC has opened its Asia Pacific Center of Excellence here with an investment of between RM5 million and RM10 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results